ZAO Bioamid was founded on November 5, 1996, subsequent to the decision on abolishing of the Saratov biocatalysis research institute due to general lack of central funding; promoters of the company were the developers of the biocatalytic acrylamide process. This technology proved to be highly demanded by a number of Russian and foreign chemical companies. In particular, the biocatalyst strain license was sold to the South Korean company Tong San. In 1998 Bioamid sold the acrylamide production process license to the German Stockhausen which is a company of the Degussa Group.
For three years Stockhausen put up money for the development of a method for producing a biocatalyst which would outperform the biocatalyst of Japanís Nitto Chemical Corp. who was the discoverer of this process. The proceeds were used for acquiring a building, equipment and financing of new researches. In particular, the company developed the first ever biocatalytic acrylic acid process and sold the license to the American Ashland Eurasia.
In 2006 the biotechnology process for producing acrylamide was sold to the Italian Europolimeri SpA. Main areas of companyís activity: chemical industry, medical science and pharmacology, agriculture, ecology.